Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 8/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | BAX | Q07812 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL27758948 | 0.94 | CA12 (0.42) | CA12CA1CA2GLACA3 | |
| Biphenyl SCHEMBL2533455 | 0.82 | NOTUM (0.44) | TDP1MMP3BCL2L1NPC1ALDH1A1 | |
| Biphenyl SCHEMBL5477829 | 0.82 | NOTUM (0.44) | TDP1MMP3BCL2L1NPC1ALDH1A1 | |
| Benzene SCHEMBL27338794 | 0.81 | PARP1 (0.33) | — | |
| Biphenyl SCHEMBL28077267 | 0.80 | NOTUM (0.42) | TDP1MMP3BCL2L1NPC1ALDH1A1 | |
| Naphthalene SCHEMBL27805984 | 0.79 | CYP2A6 (0.40) | ALDH1A1 | |
| Iodobenzene SCHEMBL27533418 | 0.78 | HDAC8 (0.33) | — | |
| Benzene SCHEMBL27557066 | 0.78 | PARP1 (0.32) | — | |
| Benzene SCHEMBL27969752 | 0.78 | PARP1 (0.32) | — | |
| Benzoic Acid SCHEMBL4289442 | 0.78 | NAPRT (0.54) | MEN1KMT2ANPC1CES2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110776475-A | Synthetic method of oxadiargyl | 安徽大学 | 2020-02-11 | — | — | CN | claimed |
| US-20210122844-A1 | Catalyst Systems Including Phenol-Oxadiazole Catalyst and Non-Coordinating Anion Type Activators Containing Cation Having Alkyl Groups and uses Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2021-04-29 | — | — | US | disclosed |
| CN-107663191-A | Polycyclic compound and the organic light emitting apparatus including the polycyclic compound | 三星显示有限公司 | 2018-02-06 | — | — | CN | disclosed |
| CN-107665954-A | Organic light emitting device | 三星显示有限公司 | 2018-02-06 | — | — | CN | disclosed |
| CN-107522719-A | Fused ring compound and the organic light emitting apparatus including the fused ring compound | 三星显示有限公司 | 2017-12-29 | — | — | CN | disclosed |
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | SYMYX TECHNOLOGIES, INC. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | WASF2, WEE1, CD40LG | CA12 3908/4885CA1 4498/4885CA2 3001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.